The group’s five-point plan provides a window into how drugmakers hoped to influence Trump — who initially backed Medicare negotiations on the campaign trail in 2016 — during the early days of his ...
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.